Equity MRK
Thursday, January 21, 2021   
Asian Paints  2714.65    (0.62%)
 
Axis Bank  675.80    (0.08%)
 
Bajaj Auto  3706.60    (1.91%)
 
Bajaj Finance  5116.65    (2.72%)
 
Bajaj Finserv  9048.50    (1.23%)
 
Bharti Airtel  580.95    (-2.56%)
 
Dr Reddy's Lab...  5052.65    (-0.51%)
 
H D F C  2662.75    (-0.97%)
 
HCL Technologi...  993.05    (-0.58%)
 
HDFC Bank  1473.90    (-1.14%)
 
Hind. Unilever  2367.10    (0.50%)
 
ICICI Bank  552.25    (0.26%)
 
IndusInd Bank  926.25    (-2.25%)
 
Infosys  1339.25    (-0.01%)
 
ITC  213.65    (-1.82%)
 
Kotak Mah. Ban...  1858.65    (-1.34%)
 
Larsen & Toubr...  1370.00    (-0.86%)
 
M & M  806.15    (-2.18%)
 
Maruti Suzuki  8073.00    (-0.85%)
 
Nestle India  17714.50    (0.21%)
 
NTPC  96.15    (-2.19%)
 
O N G C  94.90    (-4.00%)
 
Power Grid Cor...  195.00    (-0.66%)
 
Reliance Indus...  2097.85    (2.09%)
 
St Bk of India  294.95    (-2.51%)
 
Sun Pharma.Ind...  582.85    (-1.95%)
 
TCS  3274.80    (-1.01%)
 
Tech Mahindra  1003.75    (-1.52%)
 
Titan Company  1516.60    (-0.93%)
 
UltraTech Cem.  5543.30    (-0.05%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Hot Pursuit
Hester Biosciences gains on launching Live Thermo-tolerant PPR Vaccine
(15:12, 23 Nov 2020)

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DDA), Nepal, for its commercial production and marketing. The vaccine has also been tested for thermo-stability and has received a quality certification from The Pan African Veterinary Centre of the African Union (AU-PANVAC).

Hester is now geared up for commercial production and marketing of its thermo-tolerant PPR vaccine from December 2020. The vaccine will be available in packs of 25, 50 and 100 doses,” the company said in a BSE filing made during market hours today.

PPR (Peste Des Petits) or small ruminant plague is a disease of sheep and goat, with a significant impact on the livelihoods and food security of small livestock keepers across the globe, wherein 1.44 billion small ruminants are at risk and on an average 30 million animals are affected annually.

As most of the small ruminant keepers are in rural areas, the thermo-tolerant characteristic of this vaccine will ensure safe delivery of a stable vaccine in remote areas of the world where cold chain maintenance is a challenge. The thermo-tolerant vaccine could overcome the last-mile-delivery challenges.

Hester India as well as Hester Nepal have already been manufacturing the standard (non thermo-tolerant) PPR vaccine since over 5 years. The thermo-tolerant PPR vaccine will add to its range for a specific rural and backyard market mainly covering small holder livestock keepers, worldwide.

Hester Biosciences is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include poultry division and large animal division.

On a consolidated basis, the company's net profit rose 2.5% to Rs 6.68 crore on a 20.8% jump in net sales to Rs 53.41 crore in Q2 FY21 over Q2 FY20.

Powered by Capital Market - Live News